Archives for September 2020

September 2020 - Page 10 of 12 - Money Morning - Only the News You Can Profit From

How to Play the Six Most Important Stocks Right Now

by

Just last week, I showed you how the markets and the six mega-cap stocks driving them higher, were getting a bit ahead of themselves.

I don't want to be the "I told you so" guy, but… well… I'm a positive guy; positivity is a good thing, but when positivity is all there is – watch out.

Since we last spoke, the S&P 500 has shed 5%, the Dow 4%, and the mighty Nasdaq Composite – the record-smashing star performer of summer 2020 – has tanked nearly 10%.

"The bigger they are," right?

Even more than the broader S&P 500, the Nasdaq and the six 800-pound gorillas that run the show there require our immediate attention.

Don't get me wrong: It's not time to drop everything and run for the hills, but a few position tweaks, a little profit-taking, and some vigilance are in order… Full Story

Don't get me wrong: It's not time to drop everything and run for the hills, but a few position tweaks, a little profit-taking, and some vigilance are in order... Full Story

It’s Time to Short the Bond Market

by

The Fed’s backstopping of the bond market was an effort to save the U.S.

stock market, but it’s clear now that saying it and actually doing it are two very different things.

Our Shah Gilani’s takeaway from it is that it’s time to short the bond market.

And today he’ll show you exactly how to do that to ensure you’ll walk away with the most profits….

Read more...

Buy This "Post-COVID America" Money-Doubler at a Great Discount

by

The best minds in biotech are working round the clock to put a stop to the COVID-19 pandemic. The project includes over 135 vaccine candidates, and the profit potential here is massive.

This is literally about saving the world.

The thing is, though, vaccines are only one part of this project. There's another dimension, a "silent partner" in the project, that doesn't get quite so much heroic headline ink but is just as important.

You see, of all the vaccines coming down the pipeline, 31 are currently in human trials. There's a very good chance that one of them will be safe and powerful enough to begin mass distribution in early 2021.

But there are 328 million living Americans and 7.5 billion humans on planet earth. It will take time to vaccinate them all, and that's where our "silent partner" comes in.

It's blazing a trail towards the kind of better COVID-19 testing technology we will need to get things fully back to normal.

And not only that – it's on a solid track to double your money in just two years… Full Story

And not only that - it's on a solid track to double your money in just two years...

Is the Bumble IPO Worth Investing In?

by

While the coronavirus completely changed our way of life this year, something that didn't go out of style, was online dating.

Young adults have had to go months without a night life this year.

As result, they've taken to dating digitally.

That's why it was no surprise when we heard of a Bumble IPO underway.

It joins a flood of other tech IPO announcements this fall, including Snowflake, Sumo Logic, Unity, Asana, JFrog and Palantir.

You see, Bumble has been one of the winners of this post-pandemic economy...

Volatility Is Here – So Make These Trades Now

by

Our Chris Johnson recently told you September would be a volatile month – and it’s sure gotten off to a volatile start.

That means the opportunities are abundant.

And with the three trades Chris is showing you today, you’ll find out exactly how to turn volatility into your friend over the next four weeks….

Read more...

The 3 Best REITs to Buy in September

by

After months of stress due to the coronavirus, people are ready for a break.

Until then, we're focused on strategies to help you make money now.

With volatility rising into the fall and uncertainty in the economy sticking around, REITs offer a way for investors to add some stability – and cash income – to their portfolios.

That's not the only reason to buy REITs right now either.

By buying now you can lock in next quarters dividend payment.

Read more...

Is GoodRx Stock a Buy After the IPO?

by

Most of the IPO market struggled in early 2020 after the coronavirus hit.

IPO activity fell by 48%, and proceeds form IPOs fell by 67% in April-March.

Most business leaders did not trust the volatile public markets.

However, as you would expect, healthcare IPOs were a special case.

Probably due to the health scare, investors saw more opportunities in the healthcare market than anywhere else.

But is GoodRx stock a buy after the IPO?